ELL2 (eleven-nineteen lysine-rich leukemia transcription elongation factor), a component of a larger complex with pTEFb (cyclin T and CDK9) and AF4, is up-regulated in plasma cells where it influences mRNA processing by increasing exon skipping and enhancing proximal poly (A) site use. ELL2 is needed to produce the secretory-specific Ig heavy chain mRNA while ELL1 mRNA does not change in abundance with B cell stages. To investigate the potential interactions of other proteins with the ELL1 and ELL2 proteins, we preformed yeast two-hybrid studies. HSP40 and Testin were found to bind to ELL2 in its amino-terminal half. PCNA binds to ELL2 in a region encompassing amino acids 186 - 344. The potent transcription factors HIF1 α and ZNF622 interact with both ELL1 and 2 in the central, proline rich region. Meanwhile, BBS2 and ING3 interact with ELL1 but not ELL2 in this central proline-rich region. Many of the ELL-interacting-proteins uncovered in the two-hybrid screen are tumour suppressors that may work through the ELL: pTEFb complex to suppress or activate sets of genes in plasma cells.
KeywordsTranscription ElongationImmunoglobulin SynthesisYeast Two-Hybrid System
Shell, S. A., Martincic, K., Tran, J. and Milcarek, C. (2007) Increased phosphorylation of the carboxyl terminal domain of RNA polymerase II and loading of polyadenylation and co-transcriptional factors contribute to regulation of the Ig heavy chain mRNA in plasma cells. The Journal of Immunology, 179, 7663-7673.
Milcarek, C., Albring, M., Langer, C. and Park, K.S. (2011) The eleven-nineteen lysine-rich leukemia gene (ELL2) influences the histone H3 modifications accompanying the shift to secretory Immunoglobulin heavy chain mRNA production. Journal of Biological Chemistry, 286, 33795-33803. doi:10.1074/jbc.M111.272096
Martincic, K., Alkan, S.A., Cheatle, A., Borghesi, L. and Milcarek, C. (2009) Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing. Nature Immunology, 10, 1102-1109. doi:10.1038/ni.1786
Lin, C., Garrett, A.S., De Kumar, B., Smith, E.R., Gogol, M., Seidel, C., Krumlauf, R. and Shilatifard, A. (2011) Dynamic transcriptional events in embryonic stem cells mediated by the super elongation complex (SEC). Genes & Development, 25, 1486-1498. doi:10.1101/gad.2059211
Smith, E., Lin, C. and Shilatifard, A. (2011) The super elongation complex (SEC) and MLL in development and disease. Genes & Development, 25, 661-672. doi:10.1101/gad.2015411
Luo, Z., Lin, C., Guest, E., Garrett, A.S., Mohaghegh, N., Swanson, S., Marshall, S., Florens, L., Washburn, M.P. and Shilatifard, A. (2012) The super elongation complex family of RNA polymerase II elongation factors: Gene target specificity and transcriptional output. Molecular and Cellular Biology, 32, 2608-2617. doi:10.1128/MCB.00182-12
He, N., Liu, M., Hsu, J., Xue, Y., Chou, S., Burlingame, A., Krogan, N.J., Alber, T. and Zhou, Q. (2010) HIV-1 tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Molecular Cell, 38, 428438. doi:10.1016/j.molcel.2010.04.013
He, N., Chan, C.K., Sobhian, B., Chou, S., Xue, Y., Liu, M., Alber, T., Benkirane, M. and Zhou, Q. (2011) Human polymerase-associated factor complex (PAFc) connects the super elongation complex (SEC) to RNA polymerase II on chromatin. Proceedings of the National Academy of Sciences, 108, E636-E645. doi:10.1073/pnas.1107107108
Biswas, D., Milne, T.A., Basrur, V., Kim, J., ElenitobaJohnson, K.S.J., Allis, C.D. and Roeder, R.G. (2011) Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes. Proceedings of the National Academy of Sciences, 108, 15751-15756. doi:10.1073/pnas.1111498108
Barboric, M., Lenasi, T., Chen, H., Johansen, E.B., Guo, S. and Peterlin, B.M. (2009) 7SK snRNP/pTEFb couples transcription elongation with alternative splicing and is essential for vertebrate development. Proceedings of the National Academy of Sciences of the USA, 106, 77987803. doi:10.1073/pnas.0903188106
Chou, S., Upton, H., Bao, K., Schulze-Gahmen, U., Samelson, A.J., He, N., Nowak, A., Lu, H., Krogan, N.J., Zhou, Q. and Alber, T. (2013) HIV-1 tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold. Proceedings of the National Academy of Sciences, 110, E123-E131. doi:10.1073/pnas.1216971110
Luo, R.T., Lavau, C., Du, C.C., Simone, F., Polak, P.E., Kawamata, S. and Thirman, M.J. (2001) The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELLinduced leukemogenesis. Molecular and Cellular Biology, 21, 5678-5687. doi:10.1128/MCB.21.16.5678-5687.2001
Simone, F., Luo, R.T., Polak, P.E., Kaberlein, J.J. and Thirman, M.J. (2003) ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood, 101, 2355-2362. doi:10.1182/blood-2002-06-1664
Gerber, M.A., Shilatifard, A. and Eissenberg, J.C. (2005) Mutational analysis of an RNA polymerase II elongation factor in drosophila melanogaster. Molecular and Cellular Biology, 25, 7803-7811. doi:10.1128/MCB.25.17.7803-7811.2005
Li, Y., Fanning, A.S., Anderson, J.M. and Lavie, A. (2005) Structure of the conserved cytoplasmic C-terminal domain of occludin: Identification of the ZO-1 binding surface. Journal of Molecular Biology, 352, 151-164. doi:10.1016/j.jmb.2005.07.017
Liu, M., Hsu, J., Chan, C., Li, Z. and Zhou, Q. (2012) The ubiquitin ligase Siah1 controls ELL2 stability and formation of super elongation complexes to modulate gene transcription. Molecular Cell, 46, 325-334. doi:10.1016/j.molcel.2012.03.007
Wiederschain, D., Kawai, H., Gu, J., Shilatifard, A. and Yuan, Z.-M. (2003) Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. Molecular and Cellular Biology, 23, 4230-4246. doi:10.1128/MCB.23.12.4230-4246.2003
Ahn, H.-J., Cha, Y., Moon, S.-H., Jung, J.-E. and Park, K.-S. (2012) ELL3 enhances differentiation of mouse embryonic stem cells by regulating epithelial-mesenchymal transition and apoptosis. PLoS ONE, 7, e40293. doi:10.1371/journal.pone.0040293
Du, J.X., Hagos, E.G., Nandan, M.O., Bialkowska, A.B., Yu, B. and Yang, V.W. (2011) The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein. Journal of Biological Chemistry, 286, 40354-40364. doi:10.1074/jbc.M111.258707
Du, J.X., Yun, C.C., Bialkowska, A. and Yang, V.W. (2007) Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Krüppel-like factor 5. Journal of Biological Chemistry, 282, 4782-4793. doi:10.1074/jbc.M603413200
Harrold, S., Genovese, C., Kobrin, B., Morrison, S.L. and Milcarek, C. (1991) A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors. Analytical Biochemistry, 198, 19-29. doi:10.1016/0003-2697(91)90500-S
Guo, D.-F., Beyer, A.M., Yang, B., Nishimura, D.Y., Sheffield, V.C. and Rahmouni, K. (2011) Inactivation of Bardet-Biedl syndrome genes causes kidney defects. American Journal of Physiology—Renal Physiology, 300, F574-F580. doi:10.1152/ajprenal.00150.2010
Liu, L., Ai, J., Xiao, W., Liu, J., Wang, Y., Xin, D., He, Z., Guo, Y. and Wang, Z. (2010) ELL is an HIF-1α partner that regulates and responds to hypoxia response in PC3 cells. Prostate, 70, 797-805.
Xiao, W., Ai, J., Habermacher, G., Volpert, O., Yang, X., Zhang, A.-Y., Hahn, J., Cai, X. and Wang, Z. (2009) U19/Eaf2 binds to and stabilizes von Hippel-Lindau protein. Cancer Research, 69, 2599-2606. doi:10.1158/0008-5472.CAN-08-2595
Xiao, W., Jiang, F. and Wang, Z. (2006) ELL binding regulates U19/EAf2 intracellular localization, stability, and transactivation. Prostate, 66, 1-12. doi:10.1002/pros.20309
Lukashev, D. and Sitkovsky, M. (2008) Preferential expression of the novel alternative isoform I.3 of hypoxiainducible factor 1α in activated human T lymphocytes. Human Immunology, 69, 421-425. doi:10.1016/j.humimm.2008.05.004
Semenza, G.L. (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annual Review of Cell and Developmental Biology, 15, 551-578. doi:10.1146/annurev.cellbio.15.1.551
Hatano, N., Itoh, Y., Suzuki, H., Muraki, Y., Hayashi, H., Onozaki, K., Wood, I.C., Beech, D.J. and Muraki, K. (2012) Hypoxia-inducible factor-1α (HIF1α) switches on transient receptor potential ankyrin repeat 1 (TRPA1) gene expression via a hypoxia response element-like Motif to modulate cytokine release. Journal of Biological Chemistry, 287, 31962-31972. doi:10.1074/jbc.M112.361139
Sitkovsky, M. and Lukashev, D. (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1[alpha] and adenosine receptors. Nature Reviews Immunology, 5, 712-721. doi:10.1038/nri1685
Stolz, A. and Wolf, D.H. (2010) Endoplasmic reticulum associated protein degradation: A chaperone assisted journey to hell. Biochimica et Biophysica Acta (BBA)— Molecular Cell Research, 1803, 694-705. doi:10.1016/j.bbamcr.2010.02.005
Ludwig, S., Klitzsch, A. and Baniahmad, A. (2011) The ING tumor suppressors in cellular senescence and chromatin. Cell & Bioscience, 1, 25. doi:10.1186/2045-3701-1-25
Chen, G., Wang, Y., Garate, M., Zhou, J. and Li, G. (2010) The tumor suppressor ING3 is degraded by SCFSkp2mediated ubiquitin-proteasome system. Oncogene, 29, 1498-1508. doi:10.1038/onc.2009.424
Kirchmaier, A.L. (2011) Ub-family modifications at the replication fork: Regulating PCNA-interacting components. FEBS Letters, 585, 2920-2928. doi:10.1016/j.febslet.2011.08.008
Mahler, M., Miyachi, K., Peebles, C. and Fritzler, M.J. (2012) The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA). Autoimmunity Reviews, 11, 771-775. doi:10.1016/j.autrev.2012.02.012
Archacki, S.R., Angheloiu, G., Moravec, C.S., Liu, H., Topol, E.J. and Wang, Q.K. (2012) Comparative gene expression analysis between coronary arteries and internal mammary arteries identifies a role for the TES gene in endothelial cell functions relevant to coronary artery disease. Human Molecular Genetics, 21, 1364-1373. doi:10.1093/hmg/ddr574
Weeks, R., Kees, U., Song, S. and Morison, I. (2010) Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia. Molecular Cancer, 9, 163. doi:10.1186/1476-4598-9-163
Ma, H., Weng, D., Chen, Y., Huang, W., Pan, K., Wang, H., Sun, J., Wang, Q., Zhou, Z., Wang, H. and Xia, J. (2010) Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene. Molecular Cancer, 9, 190. doi:10.1186/1476-4598-9-190
Seong, H.-A., Kim, K.-T. and Ha, H. (2003) Enhancement of B-MYB transcriptional activity by ZPR9, a novel zinc finger protein. Journal of Biological Chemistry, 278, 9655-9662. doi:10.1074/jbc.M207478200